Showing results (11-20 of 63) with videos related to
Sort By:
Pageof 7
Cancer Letters|September 10, 2003
PUMA in head and neck cancerMohammad Obaidul Hoque, Shahnaz Begum, Matthias Sommer, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 29, 2009
Association between lifestyle factors and CpG island methylation in a cancer-free populationMariana Brait, Jean G Ford, Srinivas Papaiahgari, et al.International Journal of Cancer|February 4, 2018
Arsenic promotes the COX2/PGE2-SOX2 axis to increase the malignant stemness properties of urothelial cellsAkira Ooki, Asma Begum, Luigi Marchionni, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004
Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancerOzlem Topaloglu, Mohammad Obaidul Hoque, Yutaka Tokumaru, et al.Cancer Research|January 27, 2011
DeltaNp63alpha confers tumor cell resistance to cisplatin through the AKT1 transcriptional regulationTanusree Sen, Nilkantha Sen, Mariana Brait, et al.Cancer Research|August 4, 2004
Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancerMohammad Obaidul Hoque, Shahnaz Begum, Ozlem Topaloglu, et al.Cancer Research|October 3, 2003
High-throughput molecular analysis of urine sediment for the detection of bladder cancer by high-density single-nucleotide polymorphism arrayMohammad Obaidul Hoque, Juna Lee, Shahnaz Begum, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjectsMohammad Obaidul Hoque, Ozlem Topaloglu, Shahnaz Begum, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomyEli Rosenbaum, Mohammad Obaidul Hoque, Yoram Cohen, et al.Plos One|November 16, 2012
OGDHL is a modifier of AKT-dependent signaling and NF-κB functionTanusree Sen, Nilkantha Sen, Maartje G Noordhuis, et al.Pageof 7